Form NPORT-P THRIVENT SERIES FUND For: Sep 30
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Uxin Reports Unaudited Third Quarter of Fiscal Year 2024 Financial Results
- REVIVA ALERT: Bragar Eagel & Squire, P.C. is Investigating Reviva Pharmaceuticals Holdings, Inc. on Behalf of Reviva Stockholders and Encourages Investors to Contact the Firm
- TAL Education Group Announces Unaudited Financial Results for the Fourth Fiscal Quarter and the Fiscal Year 2024
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!